We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.02%
2 Healthcare 15.81%
3 Financials 11.75%
4 Consumer Discretionary 10.56%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXFT
376
DELISTED
Luxoft Holding, Inc.
LXFT
$12.5M 0.05%
223,852
-5,692
-2% -$285K
ALDR
377
DELISTED
Alder Biopharmaceuticals
ALDR
$12.4M 0.05%
1,087,209
+95,126
+10% +$1.06M
GWPH
378
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$12.4M 0.05%
94,193
-98
-0.1% -$11.5K
RRX icon
379
Regal Rexnord
RRX
$13.5B
$12.4M 0.05%
161,400
+51,000
+46% +$3.97M
RARE icon
380
Ultragenyx Pharmaceutical
RARE
$2.56B
$12.3M 0.05%
266,020
+612
+0.2% +$30K
NSC icon
381
Norfolk Southern
NSC
$75B
$12.3M 0.05%
85,059
+46
+0.1% +$6.18K
OXFD
382
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$12.3M 0.05%
881,293
-864
-0.1% -$12.7K
APLE icon
383
Apple Hospitality REIT
APLE
$3.92B
$12.3M 0.05%
627,419
+95,264
+18% +$1.84M
MPT
384
Medical Properties Trust
MPT
$2.81B
$12.3M 0.05%
892,421
+180,691
+25% +$2.44M
IAU icon
385
iShares Gold Trust
IAU
$63.8B
$12.3M 0.05%
490,050
-24,000
-5% -$589K
BIVV
386
DELISTED
Bioverativ Inc. Common Stock
BIVV
$12.1M 0.05%
224,286
-192
-0.1% -$10.5K
MSCI icon
387
MSCI
MSCI
$41.9B
$12.1M 0.05%
95,558
+31,750
+50% +$3.96M
WAL icon
388
Western Alliance Bancorporation
WAL
$8.87B
$12.1M 0.05%
+213,000
New +$11.9M
AMCX icon
389
AMC Global Media
AMCX
$427M
$12M 0.05%
222,800
-22,300
-9% -$1.19M
PLNT icon
390
Planet Fitness
PLNT
$4.43B
$12M 0.05%
347,879
-67,500
-16% -$2M
SPY icon
391
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$12M 0.05%
45,010
RXDX
392
DELISTED
Ignyta, Inc.
RXDX
$11.9M 0.05%
445,836
-462
-0.1% -$7.5K
XLF icon
393
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$11.9M 0.05%
425,000
JAZZ icon
394
Jazz Pharmaceuticals
JAZZ
$16.2B
$11.8M 0.05%
87,969
-28,893
-25% -$4.01M
CHD icon
395
Church & Dwight Co
CHD
$23.1B
$11.8M 0.05%
234,951
-5,349
-2% -$251K
VSH icon
396
Vishay Intertechnology
VSH
$5.18B
$11.8M 0.05%
567,890
+116,800
+26% +$2.5M
EWJ icon
397
iShares MSCI Japan ETF
EWJ
$22.1B
$11.8M 0.05%
196,070
-8,700
-4% -$511K
PGRE
398
DELISTED
Paramount Group
PGRE
$11.7M 0.05%
739,973
+484,191
+189% +$7.76M
GHC icon
399
Graham Holdings Company
GHC
$5.28B
$11.7M 0.05%
20,972
+100
+0.5% +$56.6K
EMB icon
400
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$11.7M 0.05%
100,550
+2,070
+2% +$239K

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.